Xinxing Li’s research while affiliated with Guangxi University of Chinese Medicine and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (2)


Total tanshinones protect against acute lung injury through the PLCγ2/NLRP3 inflammasome signaling pathway
  • Article

April 2023

·

30 Reads

·

7 Citations

Journal of Ethnopharmacology

Xinxing Li

·

Haixin Qiu

·

Jinyue Gan

·

[...]

·

Ethnopharmacological relevance: Salvia miltiorrhiza Bunge is a widely used traditional Chinese medicine with anticholinesterase, antitumor, anti-inflammatory and anti-inflammatory. Total Tanshinones (TTN), the most significant active ingredient of Salvia miltiorrhiza Bunge, exerts anti-inflammatory activity. However, the protective mechanism of total Tanshinones on acute lung injury (ALI) still needs to be explored. Aim of this study: In this study, the underlying mechanisms of TTN to treat with ALI were investigated in vitro and in vivo. Materials and methods: Cell experiments established an in vitro model of LPS-induced J774A.1 and MH-S macrophages to verify the mechanism. The levels of inflammatory cytokines (TNF-α, IL-6 and IL-1β) were estimated by ELISA. The changes of ROS, Ca2+ and NO were detected by flow cytometry. The expression levels of proteins related to the NLRP3 inflammasome were determined by Western blotting. The effect of TTN on NLRP3 inflammasome activation was examined by immunofluorescence analysis of caspase-1 p20. Male BALB/C mice were selected to establish the ALI model. The experiment was randomly divided into six groups: control, LPS, LPS + si-NC, LPA + si-Nek7, LPS + TTN, and DEX. Pathological alterations were explored by H&E staining. The expression levels of proteins related to the NLRP3 inflammasome were analyzed by Western blotting. Results: TTN decreased pro-inflammatory cytokines levels like TNF-α, IL-6, IL-1β, NO, and ROS in alveolar macrophages. TTN bound to NIMA-related kinase 7 (NEK7), a new therapeutic protein to modulate NLRP3 inflammasome and PLCγ2-PIP2 signaling pathway. In ALI mice, LPS enhanced IL-1β levels in the serum, lung tissues, and bronchoalveolar lavage fluid (BALF),which were reversed by TTN. TTN decreased cleaved-caspase-1 and NLRP3 expressions in lung tissues. When Nek7 was knocked down in mice by siRNA, the syndrome of ALI in mice was significantly suppressed, of which the effect was similar to that of TTN. Conclusions: This research demonstrates that TTN alleviated ALI by binding to NEK7 in vitro and in vivo to modulate NLRP3 inflammasome activation and PLCγ2-PIP2 signaling pathways.


Figure 1. PCA1 diminished LPS-stimulated inflammatory response in RAW264.7 cells. (A) Chemical structures of Procyanidin A1 (PCA1). (B) The cytotoxicity of PCA1 in RAW264.7 cells was determined by MTT assay after 24 h treatment. (C) RAW264.7 cells treated with PCA1 (20, 40, 80 μM) for 1 h and then induced with LPS (1 μg/ml) for 18 h. The medium was collected to determine the nitrite level using Griess Regent. (D) RAW264.7 cells treated with PCA1 (20, 40, 80 μM) for 1 h and then induced with LPS (1 μg/ml) for 18 h. iNOS and COX-2 expressions were detected by Western blotting. The grouping of gels/blots cropped from different parts of the same gel (targets vs loading control). The full blots are shown in Supplementary Information. (E) RAW264.7 cells were the treatment of PCA1 (20, 40, 80 μM) for 2 h before the co-treatment of LPS (1 μg/ml) for 6 h. Then the cells were marked with DAF-FM for 1 h, which were assessed by flow cytometry. (F) Statistical analysis of the NO per group. **p < 0.01, and ***p < 0.001 versus the LPS induced group.
Figure 2. PCA1 reduced LPS-induced pro-inflammatory cytokines in RAW264.7 cells. (A,B) RAW264.7 cells treated with PCA1 (0, 20, 40, 80 μM) for 1 h and then induced with LPS (1 μg/ml) for 18 h. The TNF-α and IL-6 level was detected using ELISA kits. (C) RAW264.7 cells were pretreated with PCA1 (0, 20, 40, 80 μM) for 1 h before co-incubation with LPS (1 μg/ml) for 8 h. Then the cells were marked with Fluo-3/AM for 1 h and assessed by flow cytometry. (D) Statistical analysis of the NO per group. *p < 0.05,**p < 0.01, and ***p < 0.001 versus the LPS group.
Figure 5. PCA1 inhibited ROS generation. (A) RAW264.7 cells treated with for PCA1 (20, 40, 80 μM) for 1 h were incubated with LPS for 8 h. Cells were stained with DCFH 2 -DA (1 μM) for 30 min. The fluorescence intensity was determined by flow cytometry at the FITC channel. (B) Statistical analysis of the ROS per group. (C) RAW264.7 cells were seeded into 96-well plates and cultured overnight. Cells pretreated with PCA1 (0, 20, 40, 80 μM) for 1 h were stimulated with LPS (1 μg/ml) for 8 h. The ROS level was determined by a ROS kit (Sigma MAK143) according to the manufacturer's instructions. (D) ROS level in cells was stained with DCFH 2 -DA. The images were captured by fluorescence microscopy. ***p < 0.001 versus the LPS group.
Figure 6. PCA1 reduced mitochondrial membrane potential (MMP). RAW264.7 cells treated with for PCA1 for 1 h were incubated with LPS for 8 h. The probe of JC-1 (5 μg/mL) was employed to detect cells for 20 min. Images were captured by fluorescence microscopy.
Figure 7. Impact of PCA1 on Keap1-Nrf2 signaling pathway in RAW264.7 cells. (A) RAW264.7 cells treated with for PCA1 for 1 h were incubated with LPS for 8 h. the expression of Keap1, Nrf2, and HO-1 were detected using Western blotting. (B) RAW264.7 cells treated with for PCA1 for 2 h were co-cultured with LPS for 2 h. The protein expression of Nrf2 in cytoplasm and nucleus were detected by Western blotting. (C-E) Statistical analysis of the Keap1, Nrf2, and HO-1 content per group. The grouping of gels/blots cropped from different parts of the same gel (targets vs loading control) or different gels (phosphorylation). The full blots are shown in Supplementary Information. *p < 0.05, **p < 0.01, and ***p < 0.001 versus the LPS induced group.

+4

Procyanidin A1 Alleviates Inflammatory Response induced by LPS through NF-κB, MAPK, and Nrf2/HO-1 Pathways in RAW264.7 cells
  • Article
  • Full-text available

October 2019

·

510 Reads

·

116 Citations

Inflammation is a complex physiological process that poses a serious threat to people’s health. However, the potential molecular mechanisms of inflammation are still not clear. Moreover, there is lack of effective anti-inflammatory drugs that meet the clinical requirement. Procyanidin A1 (PCA1) is a monomer component isolated from Procyanidin and shows various pharmacological activities. This study further demonstrated the regulatory role of PCA1 on lipopolysaccharide (LPS)-stimulated inflammatory response and oxidative stress in RAW264.7 cells. Our data showed that PCA1 dramatically attenuated the production of pro-inflammatory cytokines such as NO, iNOS, IL-6, and TNF-α in RAW264.7 cells administrated with LPS. PCA1 blocked IκB-α degradation, inhibited IKKα/β and IκBα phosphorylation, and suppressed nuclear translocation of p65 in RAW264.7 cells induced by LPS. PCA1 also suppressed the phosphorylation of JNK1/2, p38, and ERK1/2 in LPS-stimulated RAW264.7 cells. In addition, PCA1 increased the expression of HO-1, reduced the expression of Keap1, and promoted Nrf2 into the nuclear in LPS-stimulated RAW264.7 cells. Cellular thermal shift assay indicated that PCA1 bond to TLR4. Meanwhile, PCA1 inhibited the production of intracellular ROS and alleviated the depletion of mitochondrial membrane potential in vitro. Collectively, our data indicated that PCA1 exhibited a significant anti-inflammatory effect, suggesting that it is a potential agent for the treatment of inflammatory diseases.

Download

Citations (2)


... A study in 2023 showed that NEK7 expression increased with LPS application and Total tanshinones (TTN) treatment suppressed this increase. It has been shown that the increase in NLRP3 and NEK7 production is abolished by TTN treatment or inhibition of NEK7 in LPS-induced lung injury mice [49]. Considering the interaction of NEK and NLRP3 proteins, the decrease in NLRP3 expression can be revealed statistically with different sepsis experimental models and numbers. ...

Reference:

Investigation of the effects of melatonin on lung tissue through the NLRP3/TLR2/NEK7 pathway in an experimental endotoxemia model
Total tanshinones protect against acute lung injury through the PLCγ2/NLRP3 inflammasome signaling pathway
  • Citing Article
  • April 2023

Journal of Ethnopharmacology

... Similarly, OPCs protect cartilage by inhibiting synovitis, subchondral fractures, and cartilage damage, while reducing reactive oxygen species (ROS) production and MMP13 expression in monosodium iodoacetate (MIA)-induced arthritis in rats [83]. Furthermore, OPCs inhibited lipopolysaccharide (LPS)-induced inflammation, ERK1/2 phosphorylation, ROS generation, and mitochondrial membrane potential depletion in RAW264.7 cells, thereby mitigating cellular damage [84]. OPCs derived from cranberries inhibited collagen and gelatin degradation by recombinant MMP1 and MMP9 and the catalytic activity of Porphyromonas gingivalis proteases [85]. ...

Procyanidin A1 Alleviates Inflammatory Response induced by LPS through NF-κB, MAPK, and Nrf2/HO-1 Pathways in RAW264.7 cells